Picture EBD Group Biotech Showcase 2019 BTS San Francisco Investors 600x60px
Document › Details

Bruker Corporation. (1/5/2009). "Press Release: Bruker Daltonics and Queensland Institute of Medical Research Expand Collaboration with Installation of maXis™ UHR-TOF". Billerica, MA & Brisbane, QLD.

Region Region Australia
Organisation Organisation Bruker Daltonics (Operating Business of Bruker Corporation)
  Group Bruker Corporation (Group)
Products Product maXis™ Electrospray Ultra-High Resolution tandem TOF (UHR-Qq-TOF) mass spectrometer
  Product 2 proteomics
Index term Index term Queensland Institute of Medical Research–Bruker Corp: mass spectrometer, 200901– supply + collab incl installation maXis™ UHF-TOF MS system at QIMR
Person Person Seymour, Clive (Bruker Daltonics 200812 Executive VP before probably Biacore)

Bruker Daltonics and the Queensland Institute of Medical Research (QIMR) announced today the installation of the first maXis(TM) Ultra-High Resolution Time-Of-Flight (UHR-TOF) mass spectrometer in Australasia, thereby further strengthening the collaboration between Bruker and one of the premier medical research institutes in Australia.

maXis is the only instrument available today that uniquely combines the previously incompatible trends in modern mass spectrometry of ultra-high resolution and very fast chromatographic separations. Exceptional mass accuracy, high resolution and sensitivity are maintained even when coupled to the fastest liquid chromatography systems. maXis has already been proven as an exceptional tool in quantitative proteomics, peptide and intact protein analysis as well as on-the-fly unambiguous small molecule identification using the unique Smartformula(TM) 3D method.

"Bruker is delighted to further strengthen the collaborative relationship we have developed with Professor Gorman and QIMR. The installation of maXis, the first in Australasia, offers a major opportunity for us to co-develop the advanced methodologies required for the wide range of applications undertaken at QIMR's Protein Discovery Centre (PDC)," stated Clive Seymour, Executive Vice President of Bruker Daltonics.

"The installation of maXis will allow us to collaborate more extensively with Bruker, particularly in the development of ETD methodologies for the study of post-translational modifications on this exciting new platform, and represents a quantum leap in MS capability at QIMR," commented Professor Jeff Gorman, Director of the PDC. He continued: "maXis completes the stable of high resolution mass spectrometers within the facility and is a brand new technology advancing Australian science at QIMR. maXis will add significantly to the capability of the PDC to participate in the Australian government National Collaborative Research Infrastructure Scheme, funded through Bioplatforms Australia and the Queensland Government. In particular, it will provide the PDC with the scope to collaborate more effectively with scientists from QIMR, Australia and internationally on projects aimed at combating infectious diseases and cancer."

For more information about Bruker Daltonics and Bruker Corporation (NASDAQ: BRKR), please visit and

Bruker Daltonics Inc.
Clive Seymour, +64 21 640 801
Executive Vice President

Record changed: 2016-03-19


Picture [iito] – Putting Information into Context 600x60px

More documents for Bruker Corporation (Group)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture EBD Group Biotech Showcase 2019 BTS San Francisco Partnering 600x60px

» top